Atara Biotherapeutics
ATRA
ATRA
82 hedge funds and large institutions have $441M invested in Atara Biotherapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 84 → 82 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
82
Holding in Top 10
–
Calls
$452K
Puts
$5K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$7.47M | |
| 3 | +$2.58M | |
| 4 |
Neuberger Berman Group
New York
|
+$2.43M |
| 5 |
BM
Bridger Management
New York
|
+$2.12M |
Top Sellers
| 1 | -$8.55M | |
| 2 | -$4.9M | |
| 3 | -$1.71M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$909K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$510K |